Report Feature
The future of the primary cell market looks promising with opportunities in life science research companies and research institutes. The global primary cell market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing cancer research and rapid growth in the biotechnology and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global primary cell market report, please download the report brochure.
In this market, human primary cell is the largest type of primary cell, whereas life science research companies is the largest end user. Growth in various segments of the primary cell market are given below:
The study includes trends and forecast for the global primary cell market by origin, type, end user, and region as follows:
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hematopoietic Cells
- Skin Cells
- Gastrointestinal Cells
- Liver Cells
- Lung Cells
- Renal Cells
- Heart Cells
- Skeletal & Muscle Cells
- Other Primary Cells
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Human Primary Cells
- Animal Primary Cells
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Life Science Research Companies
- Research Institutes
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- German
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the primary cells model companies profiled in this report include Thermo Fisher Scientific, Merck, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences.
Lucintel forecasts that the human primary cell segment will remain the fastest growing type market over the forecast period due to high adoption of human primary cells in the development of novel cancer therapies.
Within this market, life science research companies will remain the highest growing end user segment by over the forecast period due to the increasing adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities.
North America will remain the largest region over the forecast period due to increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region.
|
Features of the Global Primary Cell Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global primary cell market by origin (hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart cells, skeletal & muscle cells, and other primary cells), type (human primary cells and animal primary cells), end user (life science research companies and research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global primary cell market? Q.5 What are the business risks and threats to the global primary cell market? Q.6 What are the emerging trends in this primary cell market and the reasons behind them? Q.7 What are some changing demands of customers in this primary cell market? Q.8 What are the new developments in this primary cell market? Which companies are leading these developments? Q.9 Who are the major players in this primary cell market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this primary cell market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global primary cell market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Origin (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells), Type (Human Primary Cells and Animal Primary Cells), and End User (Life Science Researcharmacogenetics, and Other Applications) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
4.1 Global Primary Cell Market by Region
4.2.1 Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.2.2 Market by Type: Human Primary Cells and Animal Primary Cells
4.2.3 Market by End User: Life Science Research Companies and Research Institutes
4.2.4 The United States Primary Cell Market
4.2.5 The Canadian Primary Cell Market
4.2.6 The Mexican Primary Cell Market
4.3.1 Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.3.2 Market by Type: Human Primary Cells and Animal Primary Cells
4.3.3 Market by End User: Life Science Research Companies and Research Institutes
4.3.4 The United Kingdom Primary Cell Market
4.3.5 The Spanish Primary Cell Market
4.3.6 The German Primary Cell Market
4.3.7 The French Primary Cell Market
4.4.1 Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.4.2 Market by Type: Human Primary Cells and Animal Primary Cells
4.4.3 Market by End User: Life Science Research Companies and Research Institutes
4.4.4 The Chinese Primary Cell Market
4.4.5 The Indian Primary Cell Market
4.4.6 The Japanese Primary Cell Market
4.5.1 Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.5.2 Market by Type: Human Primary Cells and Animal Primary Cells
4.5.3 Market by End User: Life Science Research Companies and Research Institutes
4.5.4 Brazilian Primary Cell Market
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
